Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway

Immunity
P M ChaudharyL Hood

Abstract

Death receptor 4 (DR4) is a recently described receptor for the cytotoxic ligand TRAIL that reportedly uses a FADD-independent pathway to induce apoptosis and does not activate the NF-kappaB pathway. We have isolated a new member of the tumor necrosis factor receptor (TNFR) family, designated DR5, which bears a high degree of sequence homology to DR4. However, contrary to the previous reports, both DR4- and DR5-induced apoptosis can be blocked by dominant-negative FADD, and both receptors can activate NF-kappaB using a TRADD-dependent pathway. Finally, both receptors can interact with FADD, TRADD, and RIP. Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.

References

May 1, 1992·Immunology Today·L A Tartaglia, D V Goeddel
Feb 17, 1995·The Journal of Biological Chemistry·M Tewari, V M Dixit
May 19, 1995·Cell·J L Cleveland, J N Ihle
Sep 10, 1993·Cell·L A TartagliaD V Goeddel
Mar 1, 1996·The Journal of Biological Chemistry·A M ChinnaiyanV M Dixit
Aug 1, 1996·Mammalian Genome : Official Journal of the International Mammalian Genome Society·M Kozak
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·T Fernandes-AlnemriE S Alnemri
Jun 1, 1996·Current Biology : CB·S A MarstersA Ashkenazi
Nov 1, 1996·Science·D J Van AntwerpI M Verma
Nov 28, 1996·Nature·J KitsonS N Farrow
Apr 4, 1997·Science·G PanV M Dixit
Oct 6, 1997·The EMBO Journal·H WalczakC T Rauch

❮ Previous
Next ❯

Citations

May 29, 1998·European Journal of Immunology·S M Mariani, P H Krammer
Nov 1, 2000·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·S H Kaufmann, G J Gores
Dec 24, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·W A Faubion, G J Gores
May 7, 2002·International Journal of Cancer. Journal International Du Cancer·Andreas EvdokiouDavid M Findlay
May 19, 2009·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Olaf HoffmannJoerg R Weber
Aug 15, 2009·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Tom M GantenHenning Walczak
Oct 27, 2004·Transplant International : Official Journal of the European Society for Organ Transplantation·Hirotaka TashiroToshimasa Asahara
Jun 15, 2007·Applied Microbiology and Biotechnology·Jiayin ShenZhimin Yin
May 3, 2005·Cancer Immunology, Immunotherapy : CII·Thomas J Sayers, William J Murphy
Nov 5, 1998·International Journal of Clinical & Laboratory Research·M Muzio
Feb 16, 2005·Apoptosis : an International Journal on Programmed Cell Death·S BouralexisA Evdokiou
Apr 14, 2007·Apoptosis : an International Journal on Programmed Cell Death·Theodore O GarnettPenelope Jayne Duerksen-Hughes
Jun 15, 2007·Apoptosis : an International Journal on Programmed Cell Death·Silvia ColucciMaria Grano
Jan 6, 2011·Apoptosis : an International Journal on Programmed Cell Death·Hyun Ho Park
Apr 25, 2007·Breast Cancer Research and Treatment·Natalya V GusevaMichael B Cohen
Sep 23, 2011·Cellular and Molecular Neurobiology·Yanli NiuJinbo Deng
Feb 24, 2007·Journal of Bioenergetics and Biomembranes·Pratima Nangia-MakkerAvraham Raz
Aug 31, 2012·Journal of Pharmacokinetics and Pharmacodynamics·Brittany P KayDavid Z D'Argenio
May 17, 2013·Cell Biochemistry and Biophysics·Giacomina BrunettiSilvia Colucci
Oct 3, 2002·Biochemical and Biophysical Research Communications·Thorsten Berger, Matthias Kretzler
May 12, 2000·Biochimica Et Biophysica Acta·C F Bennett, L M Cowsert
Aug 15, 2002·Journal of Hepatology·Jung-Hwan Yoon, Gregory J Gores
Aug 1, 1997·Journal of Hepatology·P R Galle
Mar 27, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Paula C Ashe, Mark D Berry
Mar 12, 2003·Toxicology Letters·Marion MacFarlane
Oct 31, 1998·Current Opinion in Immunology·T S Griffith, D H Lynch
Mar 26, 2003·Seminars in Cancer Biology·Nesrin Ozören, Wafik S El-Deiry
Dec 19, 2002·Cytokine & Growth Factor Reviews·Tudor M Baetu, John Hiscott
Jun 6, 2003·Cytokine & Growth Factor Reviews·Alexandru Almasan, Avi Ashkenazi
Jun 24, 1999·Cytokine & Growth Factor Reviews·H WajantP Scheurich
Feb 24, 2001·Breast Cancer Research and Treatment·M M KeaneS Lipkowitz
Apr 13, 2010·Cellular & Molecular Immunology·Duanwu ZhangJiahuai Han
Mar 24, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Helge BertramJoerg Fellenberg
Jun 20, 2013·Molecular Therapy. Nucleic Acids·Casey A MaguireBakhos A Tannous
Apr 14, 2009·Nature·Sabrina L SpencerPeter K Sorger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.